FDA Issues Multiple Recalls for Drugs and Medical Devices Due to Sterility and Performance Concerns

The FDA announced several recalls, including tirzepatide injection vials and combination injectables due to lack of sterility assurance, lubricant eye drops for potential microbiological contamination, J&J Innovative Medicine's IMAAVY injection for particulate matter, and Medtronic MiniMed insulin pumps for functional test failures. Nihon Kohden America also recalled central nurse stations due to a cybersecurity vulnerability that could disrupt patient monitoring.